Envoy Medical
COCH
Envoy Medical (COCH) news
Recent news
Envoy Medical - Enters dismissal agreement with Atlas Merchant Capital regarding Delaware litigation, on Oct 6 - SEC filing
AInvest Wire · Oct 7, 2026Envoys Medical: Q2 net loss attributable to common stockholders was $0.07 per basic and diluted share
Envoy Medical, Inc. (NASDAQ: COCH) reported its second-quarter 2026 financial results, revealing a net loss of $0.07 per basic and diluted share. The company also announced key regulatory and clinical milestones, including the completion of the second quarter and progress in its pivotal clinical…
AInvest Wire · Aug 10, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.